S310F (two cases) and V842I substitutions (two cases) in ERBB2 were recurrently detected in this study and have been functionally characterized as activating and sensitive to lapatinib in ERBB2-negative breast cancers. The gene discussed is ERBB2; the disease is breast cancer.